Related Experiment Video
Updated: May 28, 2025

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
Construction of crosstalk-free multi-functional phototherapeutic agents
Lixuan Dai1, Wenxiu Li1, Xiaoli Zhong1
1Institute of Optical Materials and Chemical Biology, Guangxi Key Laboratory of Electrochemical Energy Materials, School of Chemistry and Chemical Engineering, Guangxi University Nanning Guangxi 530004 P. R. China weiyinglin2013@163.com.
Abstract:
Phototherapeutic diagnostics has attracted ever increasing interest due to its substantial promise within conventional cancer therapeutic paradigms. Consequently, the development of multi-functional phototherapeutic agents targeting specific organelles to uncover the close association of specific organelles with apoptotic signaling pathways is particularly appealing yet difficult to achieve. Here, we propose the concept of a crosstalk-free multi-functional phototherapeutic agent. This innovative phototherapeutic agent enables the concurrent delivery of highly efficient phototherapeutic treatment and crosstalk-free imaging, employing a dual-channel strategy. Differing from predecessors with single-channel multi-functional phototherapeutic functions, we engineered a dual-channel system to mitigate the competition between non-radiative and radiative relaxation processes, enabling both high fluorescence quantum yield and high photothermal conversion efficacy in one multi-functional phototherapeutic agent. The theranostic agent NIR-Cz was designed using this concept. Last but not least, using NIR-Cz, at a cellular level and in vivo, we observed a correlation between the average quantity of lipid droplets and the degree of apoptosis, which exhibited an increase with a non-monotonic trend and variable fluctuations. The concept of crosstalk-free multi-functional phototherapeutic agents is expected to provide a suite of powerful tools to elucidate the intricate relationships between organelles and apoptotic signaling pathways.
Insights
Researchers developed a novel dual-channel phototherapeutic agent for cancer diagnostics and treatment. This agent enables crosstalk-free imaging and therapy, revealing a link between lipid droplets and apoptosis in cancer cells.
Area of Science:
- Biomedical Engineering
- Photodynamic Therapy
- Cancer Research
Background:
- Phototherapeutic diagnostics show promise in cancer treatment.
- Developing multi-functional agents for organelle targeting and apoptosis pathway analysis is challenging.
- Existing agents often suffer from functional crosstalk, limiting efficacy.
Purpose of the Study:
- To introduce the concept of a crosstalk-free multi-functional phototherapeutic agent.
- To engineer a dual-channel system for concurrent, independent therapeutic and imaging functions.
- To investigate the relationship between lipid droplets and apoptosis using a novel theranostic agent.
Main Methods:
- Designed a dual-channel phototherapeutic agent (NIR-Cz) to mitigate relaxation process competition.
- Achieved high fluorescence quantum yield and photothermal conversion efficacy simultaneously.
- Utilized NIR-Cz for cellular-level and in vivo studies to correlate lipid droplets with apoptosis.
Main Results:
- Successfully developed a multi-functional phototherapeutic agent with crosstalk-free capabilities.
- Demonstrated high fluorescence and photothermal conversion efficiency in the NIR-Cz agent.
- Observed a non-monotonic correlation between lipid droplet quantity and apoptosis degree in vitro and in vivo.
Conclusions:
- The proposed crosstalk-free dual-channel strategy overcomes limitations of single-channel agents.
- The NIR-Cz agent serves as a powerful theranostic tool for cancer research.
- This approach provides new insights into organelle-specific apoptotic signaling pathways.
More Related Videos
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
09:45Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015